Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A subtype of type 2 VWD characterized by a bleeding disorder associated with a decrease in the affinity of the Willebrand factor (von Willebrand factor; VWF) for platelets and the subendothelium in the absence of any deficiency of high molecular weight VWF multimers.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily industry-sponsored.
2 publications have been identified in PubMed for von Willebrand disease type 2M. Research spans Case Report / Case Series (50%) and Basic Science / Preclinical (50%).
Baptista D (2025). [PMID: 39991323](https://pubmed.ncbi.nlm.nih.gov/39991323/). *Cureus*. [Case Report / Case Series]
Tischer A (2025). [PMID: 39756657](https://pubmed.ncbi.nlm.nih.gov/39756657/). *J Thromb Haemost*. [Basic Science / Preclinical]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 12:51 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center